Grata is the right tool when your team has the hours to call owners and lacks a clean universe to call into. It is the wrong tool when the list already exists and nobody works it, when your targets sit below its published accuracy scope, or when the budget was never sized for a data seat. Most alternatives replace the calling, not the data.
The Grata alternatives comparison on this site lays out the other models side by side: who does the calling, where each one ends, what each one charges. This post answers a narrower question, the one a BD lead actually has when the renewal notice arrives: for a lower middle market mandate, is this seat doing the job, and if not, which job is it failing at?
Every Grata fact below comes from Grata's or Datasite's own published material, with the date we read it. Where a figure is third-party, we say so.
What Grata is in 2026
The product being renewed is not the one most firms first bought. Datasite acquired Grata on 3 June 2025 with a stated $500M investment commitment from its controlling shareholder, then acquired Sourcescrub on 8 August 2025 and announced it would merge Sourcescrub's data into Grata (datasite.com, observed 2026-09-20). Grata has since folded in Valu8's European company data (grata.com, observed 2026-09-20).
What that adds up to, per grata.com (observed 2026-09-20):
- A private-company universe Grata describes as 22M+ companies, including bootstrapped and founder-owned businesses.
- Search and enrichment: keyword and similar-company search, executive contacts, EU reported financials, conference and industry lists.
- Workflow: buyer-list management, pipeline tracking, CRM sync to Salesforce, DealCloud, Affinity and HubSpot, an Excel add-in, and an MCP server for AI assistants.
- Three proprietary layers: Seller Intent scoring, Datasite Market Intelligence drawn from Datasite's data-room activity, and MergerLinks dealmaker profiles.
- A network of active mandates, advisor-shared live deals, listed in the entry tier.
That is a serious research stack, and it keeps getting larger. None of it is the question. The question is how much of it applies to a buy box below $10M of EBITDA.
Grata vs Sourcescrub is now one question
For years, "Grata vs Sourcescrub" was a genuine choice: two private-company data vendors with different strengths. It no longer is. Both are now owned by Datasite, and the stated plan is one merged dataset.
For a firm that held both seats, that changes the renewal conversation. The practical questions are these:
- Which dataset survives where they disagree? Two sources on the same company rarely agree on revenue or headcount. Ask how conflicts are resolved in the merged product, and whether your saved lists carry over intact.
- What happens to the Sourcescrub features your team actually used? If conference lists or a particular search workflow were the reason for the seat, get it in writing that they persist.
- What is the combined price? Two contracts with one vendor is a negotiation you now hold a card in.
For a firm that held neither, the merger mostly means the incumbent in private-company data got larger. It does not change what the product does after the list is built.
When Grata is the right tool for an LMM mandate
A data seat earns its renewal when four conditions hold.
You have callers. The firm has BD staff, associates or an operating partner whose week includes owner outreach. Grata turns their hours into better-targeted hours. Without them, the seat produces exports.
The thesis is still being drawn. A new sector, an adjacent geography, a platform search where nobody yet knows how many candidates exist: similar-company search and sector mapping are fast here, and faster than building the universe by hand from trade associations and license registries.
You are building add-on or buyer lists. For a portfolio company running a buy-and-build, mapping every competitor in a region is exactly what a searchable universe with CRM sync is good at. Grata's Scale tier is pitched at mid-market PE and corp dev for this reason (grata.com/pricing, observed 2026-09-20).
Your targets sit at the top of the LMM. Grata's Seller Intent claims 98% US and 89% EMEA recall on back-tested 2025 transactions, and Grata scopes that claim to mid-market and large-cap deals (grata.com, observed 2026-09-20). A mandate at $8M to $10M of EBITDA is closer to that scope than one at $2M, and the score is more likely to mean something.
If all four hold, the alternative is not a different product. It is the same product, used harder.
When it is the wrong tool
The list exists and nobody works it. This is the most common failure and the easiest to see. If the export count for the year is in the thousands and the number of owners actually contacted is in the dozens, the constraint was never data. A second data vendor makes that worse. We cover the diagnostic in data tools vs sourcing services.
The mandate sits below the published scope. Grata publishes no breakdown of its coverage by revenue or EBITDA band (grata.com/pricing, observed 2026-09-20). That is a fact about the disclosure, not an accusation about the data. But a $2M EBITDA founder-owned distributor has usually never raised, never sold and never filed, so what the record says about its revenue is an estimate. The Seller Intent recall figures do not claim to cover it. The test is to run your own hundred known targets through a trial and count, which is the method in what to evaluate before you buy a seat.
The deal is intermediated. Many workable deals below $10M of EBITDA come through brokers and M&A advisors. Grata's active-mandates network is advisor-shared and sits behind a demo (grata.com/pricing, observed 2026-09-20). A data seat does not put your firm on a broker's short list. That takes a relationship, a record of closing, and a buyer who answers NDAs quickly.
The budget was never sized for it. Grata's entry tier is named on its pricing page for family offices and independent sponsors, and the only dollar figures Grata publishes are $20,000 and $30,000 contracts used as worked examples on its referral page (grata.com/referral, observed 2026-09-20). Third parties report the contracts as annual and auto-renewing, and Grata does not publish its terms (businessbrokerfinder.us.com, 2026-03-22). For a sponsor with one live search, that is a real line item against a pipeline that may yield one deal.
Grata pricing, in one paragraph
Grata does not publish a price. There are three tiers: Growth for family offices and independent sponsors, Scale for advisors, mid-market PE, growth equity and corp dev, and Alpha for investment banks and large funds, which adds Seller Intent and API access. Every button asks for a demo (grata.com/pricing, observed 2026-09-20). Beyond the referral-page examples above, third-party estimates range widely and none is Grata-confirmed. One circulating median rests on six purchases at a stated 30% confidence, which is not a number to budget around. The full set of anchors, with sources, is on the comparison page.
The alternatives, by what they replace
A "Grata alternative" means one of five things, depending on which part of the job is failing.
| If the gap is | The alternative is | What it does not do |
|---|---|---|
| Transacted and sponsor-backed company data | Another data vendor, e.g. PitchBook | Cover never-financed owner-operators well, or make calls |
| A narrow thesis and time to work it yourself | A self-directed deal marketplace | Show you anything nobody chose to list |
| Outbound volume you cannot staff | An outsourced outbound retainer | Cover brokered deals; its deliverable ends at a meeting |
| One specific, hard search | A buy-side broker or retained search | Scale across several mandates at once |
| Calling, verification and NDA follow-up across every channel | A platform paired with an origination team | Replace your own research and comps work |
PitchBook is the only named alternative here because it is the only other data vendor whose own filings we cite. Morningstar's FY2025 10-K lists PitchBook's competitors as Beauhurst, FactSet, MSCI, Preqin, Refinitiv and S&P Global: data providers, every one. BizNexus keeps the wider model-by-model view, including the seller-side and advisor-side reading, on its comparison of deal sourcing platforms.
The renewal audit
Before the renewal call, pull four numbers for the contract year:
- Companies exported from the seat.
- Owners contacted from those exports, meaning a real email or call and not a sequence that bounced.
- Conversations that reached the question of whether the owner would consider a sale.
- NDAs signed on companies the seat surfaced first.
If step 2 is a small fraction of step 1, the seat is not the problem, and replacing it with another database changes nothing. If steps 2 and 3 are healthy and step 4 is empty, look at the approach before the tool. If the exports themselves are thin for your sector and band, you have a real coverage question, and a trial of an alternative data source is the right next step.
Where OmniSource sits
OmniSource is not a database and does not compete with Grata on company count, search or tooling. It is a platform and an origination team on one pipeline, covering Off-Market, Pre-Market and On-Market deal flow against a documented mandate, with the team running the owner outreach, the check that a deal is live, the NDA ask and the CIM chase. A firm can run it alongside a data seat. The two answer different questions, and the renewal audit above tells you which one you are short of.